HRP20040900B1 - Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor x<sub>a</sub> - Google Patents
Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor x<sub>a</sub>Info
- Publication number
- HRP20040900B1 HRP20040900B1 HR20040900A HRP20040900A HRP20040900B1 HR P20040900 B1 HRP20040900 B1 HR P20040900B1 HR 20040900 A HR20040900 A HR 20040900A HR P20040900 A HRP20040900 A HR P20040900A HR P20040900 B1 HRP20040900 B1 HR P20040900B1
- Authority
- HR
- Croatia
- Prior art keywords
- sub
- inhibitors
- cyclopropylglycinyl
- piperidin
- certain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36852302P | 2002-04-01 | 2002-04-01 | |
| PCT/US2003/007794 WO2003084929A1 (en) | 2002-04-01 | 2003-03-24 | Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HRP20040900A2 HRP20040900A2 (en) | 2004-12-31 |
| HRP20040900B1 true HRP20040900B1 (en) | 2006-02-28 |
Family
ID=28791889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20040900A HRP20040900B1 (en) | 2002-04-01 | 2004-09-30 | Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor x<sub>a</sub> |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7166606B2 (es) |
| EP (1) | EP1492767B1 (es) |
| JP (1) | JP2005531529A (es) |
| KR (1) | KR20040094892A (es) |
| CN (1) | CN1288135C (es) |
| AT (1) | ATE303990T1 (es) |
| AU (1) | AU2003218147A1 (es) |
| BR (1) | BR0308870A (es) |
| CA (1) | CA2478340A1 (es) |
| CR (1) | CR7497A (es) |
| DE (1) | DE60301569T2 (es) |
| DK (1) | DK1492767T3 (es) |
| EA (1) | EA007300B1 (es) |
| EC (1) | ECSP045329A (es) |
| ES (1) | ES2248737T3 (es) |
| HK (1) | HK1070363A1 (es) |
| HR (1) | HRP20040900B1 (es) |
| IL (1) | IL164018A0 (es) |
| MX (1) | MXPA04009640A (es) |
| NO (1) | NO20044688L (es) |
| NZ (1) | NZ535402A (es) |
| PL (1) | PL373066A1 (es) |
| UA (1) | UA76849C2 (es) |
| WO (1) | WO2003084929A1 (es) |
| ZA (1) | ZA200407418B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6834308B1 (en) | 2000-02-17 | 2004-12-21 | Audible Magic Corporation | Method and apparatus for identifying media content presented on a media playing device |
| US7363278B2 (en) | 2001-04-05 | 2008-04-22 | Audible Magic Corporation | Copyright detection and protection system and method |
| US8972481B2 (en) | 2001-07-20 | 2015-03-03 | Audible Magic, Inc. | Playlist generation method and apparatus |
| DE102014108210A1 (de) | 2014-06-11 | 2015-12-17 | Dietrich Gulba | Rodentizid |
| WO2018093716A1 (en) * | 2016-11-18 | 2018-05-24 | Merck Sharp & Dohme Corp. | FACTOR XIIa INHIBITORS |
| EP4070658A1 (de) | 2021-04-06 | 2022-10-12 | BIORoxx GmbH | Verwendung von blutgerinnungshemmenden verbindungen als rodentizide |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8875398A (en) | 1997-08-29 | 1999-03-22 | Proteus Molecular Design Ltd | 1-amino-7-isoquinoline derivatives as serine protease inhibitors |
| EP1192132B1 (en) | 1999-06-14 | 2005-09-07 | Eli Lilly And Company | Serine protease inhibitors |
| CA2383008A1 (en) | 1999-06-14 | 2000-12-21 | Amanda Jane Lyons | Compounds |
| GB0030303D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| GB0030305D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| GB0030306D0 (en) | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| GB0030304D0 (en) * | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| TWI257389B (en) | 2001-06-12 | 2006-07-01 | Lilly Co Eli | Pharmaceutical compound |
| ATE384713T1 (de) * | 2001-07-26 | 2008-02-15 | Lilly Co Eli | 1-glycinyl-4-(1-methylpiperidin-4-yl)piperazine und -piperidine als faktor-xa-antagonisten |
-
2003
- 2003-03-24 CN CNB038074141A patent/CN1288135C/zh not_active Expired - Fee Related
- 2003-03-24 NZ NZ535402A patent/NZ535402A/en unknown
- 2003-03-24 AT AT03714138T patent/ATE303990T1/de not_active IP Right Cessation
- 2003-03-24 ES ES03714138T patent/ES2248737T3/es not_active Expired - Lifetime
- 2003-03-24 MX MXPA04009640A patent/MXPA04009640A/es active IP Right Grant
- 2003-03-24 US US10/486,138 patent/US7166606B2/en not_active Expired - Fee Related
- 2003-03-24 CA CA002478340A patent/CA2478340A1/en not_active Abandoned
- 2003-03-24 KR KR10-2004-7015486A patent/KR20040094892A/ko not_active Application Discontinuation
- 2003-03-24 PL PL03373066A patent/PL373066A1/xx unknown
- 2003-03-24 AU AU2003218147A patent/AU2003218147A1/en not_active Abandoned
- 2003-03-24 DE DE60301569T patent/DE60301569T2/de not_active Expired - Fee Related
- 2003-03-24 JP JP2003582128A patent/JP2005531529A/ja active Pending
- 2003-03-24 DK DK03714138T patent/DK1492767T3/da active
- 2003-03-24 WO PCT/US2003/007794 patent/WO2003084929A1/en active IP Right Grant
- 2003-03-24 IL IL16401803A patent/IL164018A0/xx unknown
- 2003-03-24 EP EP03714138A patent/EP1492767B1/en not_active Expired - Lifetime
- 2003-03-24 UA UA20041008649A patent/UA76849C2/uk unknown
- 2003-03-24 BR BR0308870-7A patent/BR0308870A/pt not_active IP Right Cessation
- 2003-03-24 EA EA200401290A patent/EA007300B1/ru not_active IP Right Cessation
-
2004
- 2004-09-15 ZA ZA200407418A patent/ZA200407418B/en unknown
- 2004-09-24 CR CR7497A patent/CR7497A/es unknown
- 2004-09-29 EC EC2004005329A patent/ECSP045329A/es unknown
- 2004-09-30 HR HR20040900A patent/HRP20040900B1/xx not_active IP Right Cessation
- 2004-10-29 NO NO20044688A patent/NO20044688L/no not_active Application Discontinuation
-
2005
- 2005-04-11 HK HK05103052A patent/HK1070363A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003084929A8 (en) | 2004-05-21 |
| DE60301569T2 (de) | 2006-06-14 |
| CN1288135C (zh) | 2006-12-06 |
| US20050096328A1 (en) | 2005-05-05 |
| US7166606B2 (en) | 2007-01-23 |
| EA200401290A1 (ru) | 2005-02-24 |
| ZA200407418B (en) | 2005-09-15 |
| NO20044688L (no) | 2004-10-29 |
| DE60301569D1 (de) | 2005-10-13 |
| ATE303990T1 (de) | 2005-09-15 |
| UA76849C2 (uk) | 2006-09-15 |
| KR20040094892A (ko) | 2004-11-10 |
| CR7497A (es) | 2005-01-17 |
| EP1492767B1 (en) | 2005-09-07 |
| CA2478340A1 (en) | 2003-10-16 |
| HK1070363A1 (en) | 2005-06-17 |
| JP2005531529A (ja) | 2005-10-20 |
| EP1492767A1 (en) | 2005-01-05 |
| ECSP045329A (es) | 2004-11-26 |
| DK1492767T3 (da) | 2005-11-28 |
| EA007300B1 (ru) | 2006-08-25 |
| BR0308870A (pt) | 2005-01-04 |
| HRP20040900A2 (en) | 2004-12-31 |
| PL373066A1 (en) | 2005-08-08 |
| CN1642914A (zh) | 2005-07-20 |
| ES2248737T3 (es) | 2006-03-16 |
| WO2003084929A1 (en) | 2003-10-16 |
| IL164018A0 (en) | 2005-12-18 |
| AU2003218147A1 (en) | 2003-10-20 |
| NZ535402A (en) | 2006-02-24 |
| MXPA04009640A (es) | 2005-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS2416B (is) | Pýrrólídíndíónútskipt píperídín-þalasón sem PDE4 tálmar | |
| HK1091121A1 (en) | Substituted 2-aminotetralins for the treatment of depressions | |
| GEP20074098B (en) | Lactam-containing compounds and derivatives thereof as factor xa inhibitors | |
| DE602005012634D1 (en) | Arylsulfonylnaphthalinderivate als 5ht2a-antagonisten | |
| MX2007005408A (es) | Compuestos de aminoquinazolinas. | |
| PL362834A1 (en) | Phenyl derivatives | |
| UA88163C2 (ru) | Cgrp-антагонисты, способ их получения, а также их применение как лекарственных средств | |
| IS6902A (is) | N-setin heterósýklísk NMDA/NR2B mótlyf sem ekki eru arýl | |
| RS20050046A (en) | 3-z-/1-(4-(n-((4-methyl-piperazin-1-yl)- methylcarbonyl)-n- methyl-amino)- anilino)-1-phenyl-methylene/-6- methoxycarbonyl -2-indolinone- monoethanesulphonate and the use thereof as a pharmaceutical composition | |
| WO2006047528A3 (en) | Pyrazolobenzamides and derivatives as factor xa inhibitors | |
| WO2004031145A3 (en) | Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors | |
| HK1070363A1 (en) | Certain 1-(d-cyclopropylglycinyl)-4-(piperidin-4-yl)piperazine compounds as inhibitors of the serineprotease factor xa | |
| GB0030303D0 (en) | Compounds | |
| TW200420545A (en) | 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives | |
| GB0030306D0 (en) | Compounds | |
| MX2008001778A (es) | Combinacion de un agente hipnotico y un compuesto de bis arilo y heteroarilo sustituido y aplicacion terapeutica de la misma. | |
| MXPA03010205A (es) | Derivados de acido oxalico. | |
| MY137876A (en) | Pharmaceutical compound | |
| ATE390419T1 (de) | 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-o - derivate als pde4-inhibitoren | |
| AU2002322396A1 (en) | 1-glycinyl-4 (methylpiperidin-4-yl) piperazines and -piperridines as factor xa antagonists | |
| TW200603806A (en) | Pharmaceutical compound | |
| SI1492767T1 (sl) | Dolocene 1-(d-ciklopropilglicinil)-4-(piperidin-4-il)piperazinske spojine kot inhibitorji faktorja xa serinske proteaze | |
| TW200519071A (en) | 3-aryl-2-cyano-3-hydroxy-acrylic acid derivatives | |
| AU2002366563A1 (en) | Certain glycine derivatives as factor xa inhibitors for use in the treatment of thrombotic disorders | |
| SE0302956D0 (sv) | Chemical compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| B1PR | Patent granted | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20080304 Year of fee payment: 6 |
|
| PBON | Lapse due to non-payment of renewal fee |
Effective date: 20090325 |